13.06
price up icon2.46%   0.87
 
loading
Schlusskurs vom Vortag:
$12.19
Offen:
$12.16
24-Stunden-Volumen:
319.25K
Relative Volume:
1.76
Marktkapitalisierung:
$796.44M
Einnahmen:
-
Nettoeinkommen (Verlust:
$-41.43M
KGV:
-16.53
EPS:
-0.79
Netto-Cashflow:
$-39.97M
1W Leistung:
-0.40%
1M Leistung:
+3.82%
6M Leistung:
+78.43%
1J Leistung:
+6.30%
1-Tages-Spanne:
Value
$11.82
$13.06
1-Wochen-Bereich:
Value
$11.81
$12.94
52-Wochen-Spanne:
Value
$6.00
$20.50

Gh Research Plc Stock (GHRS) Company Profile

Name
Firmenname
Gh Research Plc
Name
Telefon
-
Name
Adresse
-
Name
Mitarbeiter
50
Name
Twitter
Name
Nächster Verdiensttermin
Name
Neueste SEC-Einreichungen
Name
GHRS's Discussions on Twitter

Vergleichen Sie GHRS mit anderen Aktien

Aktien Preis Marktkapitalisierung Umsatz Nettogewinn Free Cashflow ENV
Biotechnology icon
GHRS
Gh Research Plc
13.03 796.44M 0 -41.43M -39.97M -0.79
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
456.25 115.95B 11.10B -988.90M -1.26B -3.92
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
547.21 56.52B 14.09B 4.50B 2.96B 39.28
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
325.42 39.44B 2.35B -269.70M -75.39M -2.09
Biotechnology icon
ARGX
Argen X Se Adr
555.31 35.14B 2.58B 1.06B -1.28B 16.33
Biotechnology icon
ONC
Beone Medicines Ltd Adr
246.33 28.51B 3.81B -644.79M -669.77M -6.24

Gh Research Plc Stock (GHRS) Upgrades & Downgrades

Datum Aktion Analytiker Ratingänderung
2025-06-04 Fortgesetzt Cantor Fitzgerald Overweight
2025-03-13 Eingeleitet Guggenheim Buy
2025-03-07 Eingeleitet RBC Capital Mkts Outperform
2025-02-13 Eingeleitet Cantor Fitzgerald Overweight
2022-08-16 Eingeleitet H.C. Wainwright Buy
2022-06-16 Eingeleitet ROTH Capital Buy
Alle ansehen

Gh Research Plc Aktie (GHRS) Neueste Nachrichten

pulisher
Jun 18, 2025

GH Research announces annual general meeting for July 31 - Investing.com

Jun 18, 2025
pulisher
Jun 18, 2025

GH Research Announces AGM and Key Resolutions for July 2025 - TipRanks

Jun 18, 2025
pulisher
Jun 15, 2025

J Sainsbury plc (OTCMKTS:JSAIY) Receives Consensus Recommendation of “Buy” from Analysts - Defense World

Jun 15, 2025
pulisher
Jun 13, 2025

Millennium Management LLC Acquires Shares of 20,761 GH Research PLC (NASDAQ:GHRS) - Defense World

Jun 13, 2025
pulisher
Jun 13, 2025

GH Research to Participate in Neuro Perspectives Conference - TipRanks

Jun 13, 2025
pulisher
Jun 13, 2025

Two Sigma Investments LP Makes New Investment in GH Research PLC (NASDAQ:GHRS) - Defense World

Jun 13, 2025
pulisher
Jun 11, 2025

Cantor Fitzgerald Weighs in on GH Research FY2026 Earnings - Defense World

Jun 11, 2025
pulisher
Jun 05, 2025

Cantor Fitzgerald Initiates Coverage of GH Research (GHRS) With Overweight Rating - Insider Monkey

Jun 05, 2025
pulisher
Jun 05, 2025

GH Research (NASDAQ:GHRS) Now Covered by Cantor Fitzgerald - Defense World

Jun 05, 2025
pulisher
Jun 04, 2025

GHRS Stock Coverage Initiated with Positive Outlook | GHRS Stock News - GuruFocus

Jun 04, 2025
pulisher
Jun 04, 2025

cantor fitzgerald maintains overweight rating on gh research stock By Investing.com - Investing.com Canada

Jun 04, 2025
pulisher
Jun 04, 2025

cantor fitzgerald maintains overweight rating on gh research stock - Investing.com Australia

Jun 04, 2025
pulisher
Jun 04, 2025

BNP Paribas Financial Markets Takes $44,000 Position in GH Research PLC (NASDAQ:GHRS) - Defense World

Jun 04, 2025
pulisher
Jun 02, 2025

How To Trade (GHRS) - news.stocktradersdaily.com

Jun 02, 2025
pulisher
Jun 02, 2025

Northern Trust Corp Has $286,000 Holdings in GH Research PLC (NASDAQ:GHRS) - Defense World

Jun 02, 2025
pulisher
May 27, 2025

GH Research to Present at ASCP Meeting on Breakthrough Depression Treatment - TipRanks

May 27, 2025
pulisher
May 22, 2025

(GHRS) Long Term Investment Analysis - news.stocktradersdaily.com

May 22, 2025
pulisher
May 21, 2025

GH Research to Present at ASCP Meeting on Depression Treatments - TipRanks

May 21, 2025
pulisher
May 21, 2025

GH Research PLC (NASDAQ:GHRS) Receives Consensus Recommendation of “Buy” from Brokerages - Defense World

May 21, 2025
pulisher
May 20, 2025

Beckley’s psychedelic reduces depression - BioWorld MedTech

May 20, 2025
pulisher
May 16, 2025

GH Research (NASDAQ:GHRS) Upgraded at Cantor Fitzgerald - Defense World

May 16, 2025
pulisher
May 15, 2025

GH Research (GHRS) Highlights Phase 2b Results at Clinical Confe - GuruFocus

May 15, 2025
pulisher
May 15, 2025

GH Research (GHRS) Highlights Phase 2b Results at Clinical Conference | GHRS Stock News - GuruFocus

May 15, 2025
pulisher
May 15, 2025

GH Research Showcases Promising Depression Treatment Data at ASCP Meeting - TipRanks

May 15, 2025
pulisher
May 15, 2025

GH Research Announces Acceptance of Pharmaceutical Pipeline Presentation and Late-Breaking Posters at the American Society of Clinical Psychopharmacology 2025 Annual Meeting - Yahoo

May 15, 2025
pulisher
May 12, 2025

GH Research’s (GHRS) “Buy” Rating Reiterated at HC Wainwright - Defense World

May 12, 2025
pulisher
May 12, 2025

Guggenheim Cuts GH Research (NASDAQ:GHRS) Price Target to $29.00 - Defense World

May 12, 2025
pulisher
May 10, 2025

GH Research (GHRS) Price Target Lowered by Guggenheim | GHRS Sto - GuruFocus

May 10, 2025
pulisher
May 10, 2025

GHRS Stock: HC Wainwright & Co. Reiterates Buy Rating | GHRS Sto - GuruFocus

May 10, 2025
pulisher
May 09, 2025

GH Research: Promising Clinical Results and Strong Financial Position Justify Buy Rating - TipRanks

May 09, 2025
pulisher
May 09, 2025

GH Research (GHRS) Price Target Lowered by Guggenheim | GHRS Stock News - GuruFocus

May 09, 2025
pulisher
May 09, 2025

Psychedelic: Compass, GH Research, MindMed report quarterly earnings - Yahoo Finance

May 09, 2025
pulisher
May 08, 2025

GH Research PLC Reports Earnings Results for the First Quarter Ended March 31, 2025 - marketscreener.com

May 08, 2025
pulisher
May 08, 2025

GHRS Reports Strong Financial Position with Increased Cash Holdi - GuruFocus

May 08, 2025
pulisher
May 08, 2025

GH Research Reports Q1 2025 Financial Results Amidst Ongoing Challenges - TipRanks

May 08, 2025
pulisher
May 08, 2025

GH Research PLC Reports Positive Phase 2b Trial Results for GH001 in Treatment-Resistant Depression and Financial Update for Q1 2025 - Nasdaq

May 08, 2025
pulisher
May 08, 2025

GH Research Reports First Quarter 2025 Financial Results and Provides Business Updates - Stock Titan

May 08, 2025
pulisher
May 05, 2025

What Makes GH Research (GHRS) a New Buy Stock - Yahoo Finance

May 05, 2025
pulisher
May 01, 2025

Where are the Opportunities in (GHRS) - news.stocktradersdaily.com

May 01, 2025
pulisher
May 01, 2025

Hims & Hers Health (NYSE:HIMS) Shares Down 8.3% Following Insider Selling - American Banking and Market News

May 01, 2025
pulisher
Apr 21, 2025

Legal & General Group Plc Sells 18,302 Shares of Guardant Health, Inc. (NASDAQ:GH) - Defense World

Apr 21, 2025
pulisher
Apr 18, 2025

What Will GH Research PLC (NASDAQ: GHRS) Be Like In 2025 - Stocksregister

Apr 18, 2025
pulisher
Apr 16, 2025

Psyence BioMed invests half a million into natural psychedelics operator PsyLabs - Mugglehead Magazine

Apr 16, 2025
pulisher
Apr 16, 2025

(GHRS) Pivots Trading Plans and Risk Controls - news.stocktradersdaily.com

Apr 16, 2025
pulisher
Mar 31, 2025

(GHRS) Proactive Strategies - news.stocktradersdaily.com

Mar 31, 2025
pulisher
Mar 20, 2025

JOYY, Akebia Therapeutics, Microchip Technology And Other Big Stocks Moving Lower In Thursday's Pre-Market Session - Benzinga

Mar 20, 2025
pulisher
Mar 13, 2025

Guggenheim starts GH Research at Buy, sees long-term upside potential - Yahoo Finance

Mar 13, 2025
pulisher
Mar 13, 2025

Guggenheim Initiates Coverage of GH Research (GHRS) with Buy Recommendation - Nasdaq

Mar 13, 2025
pulisher
Mar 11, 2025

GH Research PLC (GHRS) Shares Rise Despite Market Challenges - The News Heater

Mar 11, 2025
pulisher
Mar 10, 2025

How to Take Advantage of moves in (GHRS) - news.stocktradersdaily.com

Mar 10, 2025
pulisher
Mar 10, 2025

GH Research (NASDAQ:GHRS) Earns Outperform Rating from Analysts at Royal Bank of Canada - Defense World

Mar 10, 2025

Finanzdaten der Gh Research Plc-Aktie (GHRS)

Umsatz

loading

Nettogewinn

loading

Free Cashflow

loading

ENV

loading
$21.00
price up icon 1.52%
$36.00
price down icon 0.06%
$21.32
price down icon 0.15%
$99.07
price down icon 1.72%
$108.80
price up icon 2.21%
biotechnology ONC
$244.86
price up icon 1.07%
Kapitalisierung:     |  Volumen (24h):